𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer

✍ Scribed by Xiaoqun Dong; Hongwei Tang; Kenneth R. Hess; James L. Abbruzzese; Donghui Li

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
204 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine metabolic and transporter ge
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer
✍ Motofumi Tanaka; Milind Javle; Xiaoqun Dong; Cathy Eng; James L. Abbruzzese; Don πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 226 KB πŸ‘ 3 views

## Abstract ## BACKGROUND: It has not been well established whether genetic variations can be biomarkers for clinical outcome of gemcitabine therapy. The purpose of this study was to identify single nucleotide polymorphisms (SNPs) of gemcitabine metabolic and transporter genes that are associated

Polymorphisms in drug metabolism genes,
Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer
✍ Beth O. Van Emburgh; Jennifer J. Hu; Edward A. Levine; Libyadda J. Mosley; L. Do πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo

Polymorphisms in one-carbon metabolism a
Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer
✍ Lee E. Moore; NΓΊria Malats; Nathaniel Rothman; Francisco X. Real; Manolis Kogevi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 123 KB

## Abstract We have previously reported significant inverse associations between bladder cancer risk and dietary intake of vitamins B2, B6, B12, folate and protein in a hospital‐based bladder cancer case‐control study conducted in Spain (1,150 cases;1,149 controls). Because these dietary factors ar